| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |